CN1795002A - 用于治疗癌症的基于岩石粉、更具体是白云石粉的药物 - Google Patents

用于治疗癌症的基于岩石粉、更具体是白云石粉的药物 Download PDF

Info

Publication number
CN1795002A
CN1795002A CNA2004800140425A CN200480014042A CN1795002A CN 1795002 A CN1795002 A CN 1795002A CN A2004800140425 A CNA2004800140425 A CN A2004800140425A CN 200480014042 A CN200480014042 A CN 200480014042A CN 1795002 A CN1795002 A CN 1795002A
Authority
CN
China
Prior art keywords
powder
microns
mineral
added
particle size
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2004800140425A
Other languages
English (en)
Chinese (zh)
Inventor
G·特内
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CN1795002A publication Critical patent/CN1795002A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/08—Ethers or acetals acyclic, e.g. paraformaldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/12—Magnesium silicate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
CNA2004800140425A 2003-05-22 2004-05-18 用于治疗癌症的基于岩石粉、更具体是白云石粉的药物 Pending CN1795002A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10323759A DE10323759A1 (de) 2003-05-22 2003-05-22 Heilmittel zur inneren Anwendung, insbesondere gegen Krebserkrankungen
DE10323759.3 2003-05-22

Publications (1)

Publication Number Publication Date
CN1795002A true CN1795002A (zh) 2006-06-28

Family

ID=33441300

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2004800140425A Pending CN1795002A (zh) 2003-05-22 2004-05-18 用于治疗癌症的基于岩石粉、更具体是白云石粉的药物

Country Status (9)

Country Link
US (1) US20060251738A1 (enExample)
EP (1) EP1628671A1 (enExample)
JP (1) JP2006528210A (enExample)
CN (1) CN1795002A (enExample)
AU (1) AU2004243523A1 (enExample)
CA (1) CA2525908A1 (enExample)
DE (1) DE10323759A1 (enExample)
RU (1) RU2005140098A (enExample)
WO (1) WO2004105777A1 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104606261A (zh) * 2015-03-05 2015-05-13 潘友长 一种沸石药物组合物及其制备方法和用途
CN108403755A (zh) * 2018-05-03 2018-08-17 北京胜泰生物医药科技有限公司 一种沸石药物的组合、制备及用途

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE112006002042A5 (de) * 2005-05-18 2008-04-30 Mijo Ljubicic Mikronisierte mineralische Materialien und deren Herstellung
WO2007008711A2 (en) * 2005-07-08 2007-01-18 George Mason University Synthetic nanoparticle soil materials
KR101199897B1 (ko) 2011-11-14 2012-11-09 권태동 천연 광물 및 이의 용해물을 유효성분으로 함유하는 암 예방 및 치료용 조성물
KR101199895B1 (ko) 2011-11-14 2012-11-09 권태동 천연 광물 및 이의 용해물을 유효성분으로 함유하는 당뇨병 예방 및 치료용 조성물
DE102013013029A1 (de) * 2013-08-05 2015-02-05 Ernst Fekete Lobbyist-Zellschutz PNI (Psychoneuroimmunium)
RU2629338C1 (ru) * 2016-08-26 2017-08-28 Алам Джан Фармацевтическая композиция для стабилизации гомеостаза и купирования патологических процессов в организме и инъекционная лекарственная форма этой композиции
KR101996383B1 (ko) 2017-12-01 2019-07-04 (주)카데시인코퍼레이션 퓨리톤을 유효성분으로 포함하는 항암용 조성물
US20230225386A1 (en) * 2021-12-30 2023-07-20 H2 Universe Llc Hydrogen-generating composition for dietary and agricultural applications

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU200933B (en) * 1988-12-22 1990-09-28 Jozsef Markus Process for producing pharmaceutical composition for profilacting and treating osteoporosis
DE19530882A1 (de) * 1995-08-11 1997-02-13 Thomas Dr Ing Loeser Arzneimittel zur Vorbeugung, Begleittherapie und Heilung von Geschwulstkrankheiten
DE19603477A1 (de) * 1996-01-31 1997-08-07 Klaus Dr Med Reuter Tumormittel
DE59707063D1 (de) * 1996-03-25 2002-05-23 Bauer Wulf Heilmittel zur äusserlichen anwendung und verwendung einer wässrigen öl-emulsion für ein derartiges heilmittel
DE19750328A1 (de) * 1997-11-13 1999-05-20 Klaus Dr Med Reuter Tumormittel
US6251439B1 (en) * 1998-12-16 2001-06-26 Trustee Of The Dartmouth College Composition and method for reducing the risk of carcinogenesis
EP1107826A1 (de) * 1999-04-26 2001-06-20 Tihomir Lelas Vorrichtung zum mikronisieren von materialien
EP1129715A1 (de) * 2000-02-25 2001-09-05 Werner Dr. Reichen Anwendung von Magnesium, Kalzium und Silizium zur Heilung verschiedener Krankheiten und zum allgemeinen Wohlbefinden
CA2419434A1 (en) * 2000-09-19 2003-02-07 Daiichi Pharmaceutical Co., Ltd. Medicinal composition
JP2003063951A (ja) * 2001-08-23 2003-03-05 Nonogawa Shoji Kk 錠剤及びその製造方法
DE10323758A1 (de) * 2003-05-22 2004-12-16 Bauer, Wulf, Dr. Heilmittel zur inneren Anwendung, insbesondere gegen Krebserkrankungen

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104606261A (zh) * 2015-03-05 2015-05-13 潘友长 一种沸石药物组合物及其制备方法和用途
CN104606261B (zh) * 2015-03-05 2018-02-09 潘友长 一种沸石药物组合物及其制备方法和用途
CN108403755A (zh) * 2018-05-03 2018-08-17 北京胜泰生物医药科技有限公司 一种沸石药物的组合、制备及用途

Also Published As

Publication number Publication date
AU2004243523A1 (en) 2004-12-09
US20060251738A1 (en) 2006-11-09
EP1628671A1 (de) 2006-03-01
CA2525908A1 (en) 2004-12-09
DE10323759A1 (de) 2004-12-16
JP2006528210A (ja) 2006-12-14
WO2004105777A1 (de) 2004-12-09
RU2005140098A (ru) 2006-08-10

Similar Documents

Publication Publication Date Title
CN1194827A (zh) 自由流动的干燥颗粒
Farshi Azhar et al. The effect of montmorillonite in graphene oxide/chitosan nanocomposite on controlled release of gemcitabine
CN1748777A (zh) 一种中药挥发油自微乳化纳米组合物及制备方法
CN1795002A (zh) 用于治疗癌症的基于岩石粉、更具体是白云石粉的药物
KR20160124797A (ko) 안정화된 중합체 실리케이트 조성물과 관련된 물질 및 방법
KR20190010542A (ko) 포유동물 조직 중의 산소량을 증가시키는 포접체를 포함하는 다중산소화된 금속 하이드록사이드
CN88102143A (zh) 无悬浮剂的稳定的碱式蔗糖硫酸铝悬液药物组合物
Jiang et al. Hydrogen therapy: recent advances and emerging materials
US11007217B2 (en) Compositions comprising nanosilica particles and their use in methods of activating T lymphocytes for therapy
JP2006528210A5 (enExample)
CN114209851A (zh) 一种姜黄素-氧化硅纳米载药体系及其制备方法和应用
Cheng et al. Tailoring biomaterials ameliorate inflammatory bone loss
Li et al. Silicon or calcium doping coordinates the immunostimulatory effects of aluminum oxyhydroxide nanoadjuvants in prophylactic vaccines
US20070172435A1 (en) Medicament for internal application, in particular against cancerous diseases
Ambarish et al. Zeolites: microporous natural mineral carrier in controlled, targeted (nanocarriers) and gene delivery systems
Xia et al. Preparation and in vitro antitumor study of two-dimensional muscovite nanosheets
CN101036785A (zh) 肝炎疫苗的壳聚糖纳米粒口服制剂
Bhosale et al. Nanodiamonds: a new-fangled drug delivery system
CN102099023A (zh) 用于活化干细胞的药剂
CN1193790C (zh) 胸腺肽组合物注射剂及其制备方法
CN1212130C (zh) 一种治疗牛皮癣、鱼鳞病和湿疹的药物
CN1468602A (zh) 柚皮苷在制备支持性治疗非典型性肺炎药物中的应用
CN1181881C (zh) 一种治疗口腔溃疡的药
CN110625130B (zh) 埃米银、埃米银外用凝胶及制备方法和应用
KR101986510B1 (ko) 금나노 입자가 분산되어 있는 숙취해소제, 건강보조식품 및 그 제조방법

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication